SDIC Venture Capital

SDIC Venture Capital Co., Ltd. is a venture capital firm headquartered in Beijing, China, with an additional office in Shanghai. Established in 2016 by the State Development and Investment Corporation, SDICVC operates under a market-driven governance structure. It aims to advance the commercialization of the nation's scientific and technological achievements, aligning its investment strategy with national innovation goals. The firm manages a portfolio of funds with a total asset under management of RMB 14 billion, focusing on the transformation of technological advancements. SDICVC seeks to blend the interests of government, society, and the market, positioning itself as a reliable and respected partner in the venture capital landscape. Its mission is underscored by a commitment to achieving policy orientation and investment returns while fostering synergy among various stakeholders.

Zhuoxi Chen

VP

Zhi Xiao

Managing Partner

178 past transactions

FutureFab.AI

Series A in 2025
Zhixian Future is a provider of engineering intelligent system solutions driven by multi-modal large models, serving more than 180 benchmark semiconductor customers.

Yijin New Energy

Series C in 2025
Yijin New Energy focuses on developing and making lithium battery materials and new battery technologies.

Ouye Semiconductor

Series B in 2025
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Leadrive

Series E in 2025
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

Cholesgen Pharmaceutical

Series A in 2025
Cholesgen Pharmaceutical is a biopharmaceutical company focused on developing innovative drugs for metabolic diseases and conditions related to tumor treatment. The company leverages advanced technologies such as reporter gene screening systems, protein-small molecule interaction systems, and in vitro drug efficacy tests. These tools are integrated into an independent research and development platform that optimizes drug discovery through biochemical and cell testing. Cholesgen's approach is grounded in biochemistry, disease biology, medicinal chemistry, and clinical translational medicine, aiming to provide the medical industry with cutting-edge solutions for new disease targets.

Kemi Biotech

Seed Round in 2025
Kemi Biotech is a preclinical immunotherapy product development company .

Qingke Jiahe

Series B in 2025
Qingke Jiahe manufactures semiconductor liquid pipelines, precision instrument systems, and other semiconductor equipment core components.

Zhejiang Xinglaihe

Venture Round in 2025
Zhejiang Xinglaihe is a modern agricultural machinery manufacturing company. It is committed to the research and development, manufacturing, and sale of high-speed rice transplanters, tractors, diesel engines, and other agricultural machinery.

Juli Automation Equipment

Private Equity Round in 2025
Juli Automation is a specialized manufacturer and developer of components for electric vehicles (EVs). The company's core business revolves around flat wire motor technology, offering comprehensive solutions for motor winding and assembly. Juli Automation serves international automotive original equipment manufacturers (OEMs) and has pioneered advancements like China's first automated EV motor stator line using hairpin technology, enhancing EV motor production efficiency. The company is committed to research and development, driving innovation in new energy vehicle motor manufacturing and contributing to the global EV industry's growth.

BOPIXEL

Series A in 2024
BoPixel specializes in providing core components and system solutions for high-performance machine vision applications. The company manufactures industrial cameras, digital light processing projectors, and other essential components used in various industries, including automotive, logistics, food, and pharmaceuticals. By focusing on vision inspection and measurement, BoPixel aims to enhance the capabilities of machine vision technology, supporting sectors such as semiconductors, new energy, and consumer electronics. Through its innovative solutions, BoPixel is committed to advancing the development and implementation of machine vision systems across multiple industries.

Unisic Technology

Series B in 2024
Unisic Technology specializes in designing and manufacturing silicon carbide core power components and semiconductor modules. The company develops a range of products utilizing third-generation silicon carbide materials, including semiconductor power modules and driver circuits. Unisic applies its silicon carbide technology across various critical sectors such as aviation, new energy power generation, high-end medical care, oil exploration, lighting, new energy vehicles, and data centers. By offering customized application solutions, Unisic Technology addresses the unique needs of its clients in these important fields, enhancing the performance and efficiency of power systems.

Affinity

Series B in 2024
Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs.

Ouye Semiconductor

Series B in 2024
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Xijia Precision

Venture Round in 2024
Xijia Precision provides polymer elastomers and high-functional plastic components.

Qiyuan Gas

Series C in 2024
Qiyuan Gas is an electronic gas company that offers xenon, krypton, helium, ultra-pure oxygen, carbon dioxide, and other items. It also offers high-end gas system solutions to semiconductor, flat panel display, aerospace, medical, and other industries.

Shanghai Lixin

Series B in 2024
Lixin specializes in the research and development of full-process tools for the industry.

Kaihong Digital

Series A in 2024
Kaihong Digital is an IoT operating system developer which focuses on developing IoT operating systems. The company's business model combines AloT operating system consultancy, R&D, customisation, delivery, and after-sales services to provide users with pan-intelligent terminal operating system technology and products.

Weikang Bio

Venture Round in 2024
Weikang Bio is a medical research company that engages in the development, production, and product service of probiotics and derivatives.

MoonBiotech

Series C in 2024
MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

Dachao Carbon Energy

Series B in 2024
Dachao Carbon Energy is an energy-tech company that specializes in the R&D, production, and sales of advanced carbon-based materials.

Noding Intelligence

Series B in 2024
Noding Intelligence is a pan-semiconductor testing equipment R&D and manufacturing company.

Mitro Biotech

Venture Round in 2024
Mitro Biotech is a domestic molecular imaging medical research and development outsourcing enterprise that specializes in contract research services aimed at shortening the drug development cycle and minimizing the risk of failure. The company offers a comprehensive suite of solutions for both domestic and international pharmaceutical companies and research institutions. Its services encompass drug screening, biodistribution studies, pharmacokinetic research, and pharmacodynamic evaluation, thereby facilitating the efficient introduction of new drugs to the market. By providing these essential services, Mitro Biotech enables pharmaceutical developers to expedite the transition of their products from the research phase to clinical trials and eventual market launch.

Xunlian Technology

Series B in 2024
Xunlian Technology is a manufacturer of measuring, control, communication, and navigation devices. Xunlian Technology provides measurement and control communication equipment and services for drones, satellites, rockets, and so on. Satellite navigation core electrical equipment.

Taihe Petrochemical

Venture Round in 2024
Taihe Petrochemical is a fluid control, industrial process solutions, and fluid technology consulting company that provides research and development, design, production, sales, and technical services for valves, pipe fittings, and other products.

HQ-Nano Integrated Circuit

Series A in 2024
HQ-Nano is an integrated circuit analysis and testing service platform that focuses on the development of high-end chip analysis technology and testing services.

Guangduo Micro-Nano Technology

Series B in 2024
Guangduo Micro-Nano Technology is dedicated to nanoimprint equipment and technology research and development as well as industrial promotion and application. It has created and manufactured a wide range of nanoimprint equipment, supporting processes, and consumables, and has successfully launched a completely automated system.The industrialization of mass-produced nanoimprint equipment has resulted in the industrial replacement of stepper lithography machines in the LED sector.

Join Silicon

Series B in 2024
JoinSilicon specializes in providing customized solutions for the semiconductor industry, focusing on chip custom design, system and embedded software design and verification, and integrated circuit package design. The company offers a comprehensive range of services, including simulation and testing, chip design services, and one-stop ASIC design solutions. By transforming application software into transistor-level layouts, JoinSilicon supports clients across various sectors, such as server and computing, automotive, Internet of Things (IoT), and networking. Their extensive experience in co-developing hardware and software enables clients to effectively translate their innovative ideas into tangible products.

AOSSCI

Venture Round in 2023
AOSSCI is a developer of unmanned aerial vehicle (UAV) systems and control technologies designed for a range of industrial applications. The company specializes in high-performance all-electric drones, ground control stations, and flight simulation platforms that facilitate integrated flight control training. AOSSCI’s products are utilized in diverse sectors such as land surveying, public safety, power line inspection, resource exploration, and environmental protection. The company is committed to delivering innovative UAV solutions that enhance operational efficiency and safety across various industries, including oil exploration, landscape mapping, and smart urban management.

AlpsenTek

Series B in 2023
AlpsenTek is a high-tech company specializing in the research and development of machine vision sensors and algorithms. It has created advanced machine vision imagers featuring innovative pixel structures, alongside comprehensive solutions that encompass modules, algorithms, and systems. Drawing on its team's extensive expertise in vision sensors, system-on-chip technology, and imaging signal processing, AlpsenTek aims to enhance the machine vision ecosystem. The company's technology includes hybrid biomimetic vision chips and integrated solutions, which are applicable in diverse fields such as robotics, autonomous driving, consumer electronics, surveillance, and industrial monitoring. By providing dynamic light sensing capabilities and biomimetic functions, AlpsenTek addresses the evolving needs of various industries, positioning itself as a key player in the machine vision market.

Bintie Biotechnology

Series A in 2023
Bintie Biotechnology is a pioneering biomedical technology enterprise in the clinical stage. Its primary products are novel immune cell formulations intended to target solid tumors.

Bangxin Semiconductor

Series B in 2023
Bangxin Semiconductor specializes in manufacturing semiconductor equipment, catering to the integrated circuit and broader semiconductor industries. The company's core focus lies in four key areas: compound semiconductors, integrated circuits, packaging and testing, and panel industries. It continually works on developing new equipment and supporting emerging manufacturing processes for both compound and silicon chip industries.

Northern Yiheng

Series B in 2023
Northern Yiheng is a producer of composite insulation materials made of semiconductor graphite fiber.

Century Kangtai

Series B in 2023
Century Kangtai is a Class III medical device manufacturer that combines production, research and development, and sales. Century Kangtai is a collagen material developer and ophthalmic clinical trial company. Its primary business is the research and development, production, and marketing of ocular implant devices, as well as the provision of after-sales services to consumers. It has computer numerical control air suspension and uses laser navigation technology and laser interference. Products that use measurement technology include integrated posterior chamber intraocular lenses, ocular fixation rings, and collagen sponges.

Guohua Technology

Venture Round in 2023
Guohua Technology specializes on ceramic material research and development. It is a company that specializes in microwave ceramic functional materials. It is a limited liability corporation that produces microwave communication devices and useful ceramic materials.

Canton Biologics

Series C in 2023
Canton Biologics is a contract development and manufacturing organization based in China that specializes in the research and development of biologic drugs. The company offers a range of services tailored for the biopharmaceutical industry, including clinical and commercial production. Canton Biologics focuses on the development and production of biomacromolecule drugs, such as monoclonal antibodies, double antibodies, fusion proteins, and recombinant proteins. With a commitment to advancing biologic drug development, Canton Biologics plays a pivotal role in supporting the needs of biopharma companies and contract research organizations.

Shengqiang Technology

Series B in 2023
Shengqiang Technology is an autonomous, innovative high-tech firm that combines R&D, manufacturing, and commercialization. It has adhered to its development strategy of being a leader in pathology digitalization, a creator of pathology information, an integrator of pathology intelligence, and an advocate for functional pathology from its inception.

Jinfang Pharmaceutical

Venture Round in 2023
Jinfang Pharmaceutical is focused on R&D and drug development from small molecule drug pipelines to diversified cutting-edge therapies.

ATOMsci

Series A in 2023
ATOMsci is a manufacturer of optoelectronic equipment that sells Raman spectrometers, photodetectors, lasers, and laser applications.

Fullcryo

Series C in 2023
Fullcryo provides solutions for helium extraction from natural gas, hydrogen liquefaction, and liquefied hydrogen storage.

Dehui Electronics

Venture Round in 2023
Dehui Electronics develops, manufactures, and sells high-performance electronic ceramics and related electronic components.

Time Speed

Venture Round in 2023
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Yanming Biology

Series A in 2023
Pyrotech pharmaceuticals is a biotechnology company that focuses om development for drugs for the treatment of inflammation and tumors.

Hithium Energy Storage

Series C in 2023
Hithium Energy Storage is a technology enterprise that focuses on the research, development, production, and sales of lithium-ion battery core materials and lithium iron phosphate (LFP) energy storage batteries and systems. The company aims to provide safe, efficient, clean, and sustainable energy storage solutions for its clients. Hithium has made significant advancements in battery safety and longevity, supported by four research and development centers and multiple intelligent production facilities. Through its innovations, Hithium is positioned to address the growing demand for reliable energy storage in various applications.

Sinotau

Series E in 2023
SinoTau is a comprehensive solution provider in the pharmaceutical sector, focusing on both generic and innovative drugs. The company specializes in the early development of antibody biopharmaceuticals and produces advanced generic medications. It aims to address various therapeutic areas, including cardiovascular diseases, neurodegeneration, and tumors. SinoTau's expertise encompasses medicinal chemical synthesis, generic drug analysis, pharmaceutical preparations, and drug registration, supported by leading research in targeted drug development. The company leverages advanced diagnostic methods and monoclonal antibody technologies to enhance its offerings, positioning itself as a key player in the biotechnology industry.

Chenyao Technology

Seed Round in 2023
Chenyao Technology is a high-tech company that provides mobile office security services.It is a service provider for the new infrastructure of mobile office security, providing a uniform security management platform and secure access services to all workers who use mobile smart terminals in the new era.

Huaxun Semiconductor

Venture Round in 2023
Huaxun Semiconductor is a high-tech firm specialized in R&D, production, and distribution of essential materials for advanced integrated circuit packaging.The company focuses on providing system solutions and key materials for ultra-thin wafer processing and holding, ultra-thin device manufacturing, three-dimensional stack packaging, flexible display, conductive interconnection, and other fields, guided by the lightness, thinness, and shortness of integrated circuits.

HongHu Semiconductor

Series A in 2023
HongHu Semiconductor is a company focused on the research, development, and manufacturing of semiconductor equipment tailored to local market needs. They produce a variety of products such as Equipment Front End Module (EFEM), Automatic Wafer Transfer Machine (Sorter), Vacuum Transfer Platform (VTM), and Semiconductor Precision Components. Their offerings include wafer automatic transfer technology, equipment solutions, and semiconductor consumable spare parts services, catering to large-scale wafer production lines, chip manufacturers, semiconductor equipment producers, and advanced packaging facilities.

VJTBio

Series C in 2023
VJTBio is a biopharmaceutical company specializing in the high-end animal protein pharmaceutical market. It develops innovative biopharmaceuticals aimed at enhancing reproductive and immune health in animals. Utilizing genetic recombination techniques, the company focuses on solutions for animal reproduction, disease prevention, and pet health. In addition to its research and development efforts, VJTBio is involved in the production and sales of advanced treatments for animal health, offering clinical testing and technical services to the biopharmaceutical industry and medical professionals.

Eceyes Internet Financial

Series D in 2023
Eceyes Internet Financial is an insurance technology platform offering insurance and related products.

Life Biosciences

Series A in 2023
Life Biosciences specializes in animal behaviour analysis services, supporting scientific research with a comprehensive suite of offerings including blood biochemistry tests, routine blood examinations, pathological staining, immunohistochemistry, molecular and cellular experiments, flow cytometry, X-ray irradiation, and nuclear magnetic resonance imaging. They also provide experimental animal model resources, large animal disease models, testing, imaging, foster care, decontamination services, further facilitating laboratory animal research within the scientific community.

Jianan Nongmu

Venture Round in 2023
Jianan Nongmu builds a new model of the agriculture and animal husbandry industry. The company is divided into three business units: digital supply chain financing, smart breeding, and smart logistics. Jianan Nongmu is dedicated to bringing back the agriculture and animal husbandry sectors of the economy through science and technology.

SinceVision

Series C in 2023
SinceVision is a manufacturing company that provides high-speed cameras, 3D laser profilers, sensors, and technical support services.

Surgerii Technology

Series C in 2023
Beijing Surgerii Technology Co., Ltd. specializes in the research, development, production, and sale of minimally invasive surgical robot systems in China. Founded in 2014 and based in Beijing, the company focuses on innovative technologies, particularly the next generation of flexible continuum robotic arms. Surgerii Technology aims to transform clinical practices through its single-hole and porous laparoscopic robot systems, enhancing the standard of care in minimally invasive surgeries. With a commitment to independent research and development, the company leverages its expertise in system design and integration to advance the medical equipment industry in China.

HongFuCheng

Venture Round in 2023
HongFuCheng specializes in the integration of research, development, manufacturing, and sales of advanced materials. The company produces innovative solutions including electromagnetic interference (EMI) shielding materials, thermal interface materials, and wave-absorbing materials. These products are tailored for various applications, particularly in mobile phones, new energy vehicles, and optical modules. By focusing on high-quality materials, HongFuCheng supports its clients in achieving enhanced performance and reliability in their technological offerings.

Zhishan Weixin Biotechnology

Series A in 2023
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.

Spectron Technologies

Seed Round in 2023
Spectron Technologies specializes in providing advanced communication solutions, focusing on low-band and filtering technologies. The company offers a range of filter-assisted solutions designed to enhance the architecture of mobile products for their partners' customers. Spectron Technologies enables scalable manufacturing processes, allowing clients to adopt innovative operational strategies. Their portfolio includes filters and microsystems that facilitate breakthrough communication platforms, with a particular emphasis on 5G products tailored to the dynamic demands of the marketplace.

Yike Polymers

Series B in 2023
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

Ruidiwei

Series C in 2023
Chengdu Ruidiwei Technology Co., Ltd. is a technology company based in Chengdu, China, established in 2014. The company focuses on the design, development, production, sales, and service of antennas, components, and chips that operate in microwave and millimeter-wave frequency bands. Ruidiwei aims to deliver innovative solutions in the telecommunications sector, contributing to advancements in wireless communication technology.

Yuze Semiconductor

Series B in 2023
Yuze Semiconductor is a research and development manufacturer of N-type solar monocrystalline silicon rods and silicon wafers. It was established in 2019 and is headquartered in China.

WITINMEM

Series B in 2023
Beijing Witinmem Technology Co., Ltd., founded in October 2017, specializes in artificial intelligence chips and system solutions utilizing processing-in-memory technology in NOR Flash memory. The company's innovative technology enables the execution of deep neural network inference directly within the NOR Flash memory, which significantly enhances performance, power efficiency, and accuracy. Witinmem's solutions are particularly applicable in speech and image processing, positioning the company at the forefront of low-cost, low-power AI chip development. By facilitating local AI processing independent of cloud resources, Witinmem is dedicated to advancing the integration of AI into everyday smart devices. The company is headquartered in Beijing, China.

KM Soft

Venture Round in 2022
KM Soft software is used in equipment manufacturing enterprises such as aviation, aerospace, aviation development, shipbuilding, electronics, automobiles, and construction machinery. Their software product center includes digital platforms, digital research and development, digital process, digital manufacturing, and 3D tool software.

AccuSilicon

Series F in 2022
Accusilicon Inc. is a manufacturer based in Santa Clara, California, specializing in TCXO IC chips. Founded in 2011, the company focuses on producing high-performance audiophile crystal oscillators and ultra-low phase jitter PLL and DIR modules, catering to audiophile applications. In addition to its audio technology, Accusilicon develops integrated circuit chips that enhance clock performance for mobile communications, improving data speeds for devices such as cell phones and high-speed Ethernet. This technology enables consumers to access faster internet connections at a lower cost, making Accusilicon a key player in the audio and mobile communication sectors.

Safe Medical Evaluation

Series D in 2022
SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.

Weishi Energy

Series B in 2022
Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

Grace Laser

Series C in 2022
Grace Laser Technology Co., Ltd., established in 2014 and headquartered in Beijing, China, specializes in the development of laser devices for various applications, including scientific research, industrial processing, and medical aesthetics. The company is committed to advancing the national laser industry and aims to establish a renowned domestic laser brand. Grace Laser possesses a comprehensive research and development, production, and quality management system, which enables it to deliver high-quality laser products and services to its clients.

Vivest

Series B in 2022
Vivest engages in R&D of emergency medical equipment.

Xindi Digital Engineering System

Venture Round in 2022
Xindi Digital Engineering System specializes in the development of commercial software products for computer-aided design (CAD), focusing on 3D technology. The company creates CAD content compatible with a variety of systems, including AutoCAD, SolidWorks, CATIA, UG, Pro/E, Inventor, Solid Edge, Geomagic, Maya, and 3D Studio Max. By providing these solutions, Xindi enables manufacturing enterprises to efficiently establish comprehensive digital product development and design systems.

GBase

Post in 2022
GBase is a provider of database software solutions based in China, specializing in the development of products tailored for various industries, including finance, telecommunications, government, energy, transportation, and national defense. The company focuses on enabling enterprises to utilize domestically developed software, which supports their operational needs and enhances data management capabilities. GBase's offerings are designed to meet the specific requirements of its clients, facilitating improved performance and efficiency in data handling across diverse sectors.

Ningbo Testo Technology

Series A in 2022
Ningbo Testo Technology is a developer of back-end domestic EDA software and is committed to solving the electromagnetic compatibility and signal integrity problems caused by the increase in the operating frequency of integrated circuits in the post-Moore era, as well as dealing with new physical problems caused by chip process and material innovation. such as power integrity and thermal stability issues.

Jialichuang

Series B in 2022
JLCPCB is the globally leading PCB prototype enterprise and a high-tech manufacturer specializing in quick PCB prototype and small-batch PCB production. With over 14 years of experience in PCB manufacturing, JLCPCB has more than 800,000 customers all over the world, with over 18,000 online orders of PCB prototyping and small quantity PCB production per day. The annual production capacity is 600,000 sq.m. for various 1-layer, 2-layer or multi-layer PCBs. JLC is a professional PCB manufacturer featured of large scale, well equipment, strict management, and superior quality.

Linkingfresh.com

Series B in 2022
Linkingfresh.com, established in 2018 and headquartered in Qingdao, China, operates as an online platform dedicated to commodity trading and international fresh harvesting services. The company facilitates a comprehensive range of offerings, including international warehousing logistics, internet finance, and distribution processing. It serves as a pivotal link in the fresh industry, connecting major international manufacturers from over 20 countries, such as the United States, Canada, and the Netherlands, with participants throughout the fresh industry chain. Linkingfresh.com provides access to thousands of high-quality direct supply products, including fresh animal protein such as pork, beef, poultry, seafood, and various meat products, thereby supporting both international and domestic supply chains.

Viiyong

Series B in 2022
Viiyong is a manufacturer based in Shenzhen, China, specializing in multi-layer ceramic chip capacitors. Founded in 2001, the company emphasizes research and development to produce high-end capacitor solutions tailored for the automotive electronics industry. Through its innovative approach, Viiyong aims to meet the evolving needs of customers by providing advanced capacitor products that enhance electronic performance and reliability.

Canwell Biotech

Series A in 2022
Canwell Biotech is a drug research and development company that specializes in creating innovative anti-tumor therapies. The company is dedicated to the development and commercialization of First-in-Class and Best-in-Class immunotherapy drugs, aiming to enhance treatment efficacy for patients. Through its focus on advanced drug development, Canwell Biotech seeks to provide effective solutions in the fight against cancer.

Zhiyi Pharmaceutics

Series B in 2022
Zhiyi Pharmaceutics Inc., established in 2013 and based in Guangzhou, China, specializes in the research and development of next-generation probiotics (NGPs) and live biotherapeutics (LBPs). The company's product pipeline includes SK08, TP2, ZY19, and SK09, all targeted at treating gastrointestinal disorders. Zhiyi Pharmaceutics focuses on innovative drug discovery, with a particular emphasis on the development of its proprietary strain SK08, which is poised to enter clinical trials. The company aims to expand its research into the relationship between human microbiome and disease, including microbial culture groups and pathobionts research, as well as the identification and separation of new functional strains.

Dakang Medical

Series E in 2022
Dakang Medical operates a network of independent medical facilities specializing in blood purification services for kidney disease. The company focuses on providing advanced treatments such as hemodialysis, hemofiltration, and peritoneal dialysis, utilizing state-of-the-art medical technology. Dakang Medical emphasizes a patient-centered approach, aiming to create a warm and supportive environment to enhance the treatment experience for individuals suffering from nephropathy. In addition to its clinical services, Dakang Medical is involved in medical investment and the management of medical institutions, as well as offering brand operation services within the healthcare sector.

TBSTest

Venture Round in 2022
TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.

Ouye Semiconductor

Seed Round in 2022
Ouyeel Semiconductor is a manufacturer of SoC chips. They offer smart car chips and solutions for automakers, enabling customers to reduce costs and time to develop new products and features.

Yuansheng Pixel

Seed Round in 2022
Pixel offers AI, data algorithm, neural expansion that solves data technology problems and provides intelligent marketing solutions .

Weikaier Pharmaceutical Technology

Series A in 2022
Weikaier Pharmaceutical provides R&D of innovative drugs, transfer of generic drug technology, the production and sales of pharmaceuticals.

Beilai Bio

Series B in 2022
Beilai Bio is a clinical-stage biopharmaceutical company focused on the development of stem cell therapeutics for various diseases, particularly those with high unmet medical needs. Its established technology platforms allow them to produce clinical-grade "off-the-shelf" Human Umbilical Cord Mesenchymal Stem Cells (hUC-MSC) from an unlimited supply of cord tissues that are traditionally regarded as medical waste.

Yihui Information

Series B in 2022
Yihui Information provides technical assistance and integrated hardware and software solutions. They also offer development kits, virtualization, cloud native that includes mission-critical cloud native, microservices architecture, container management services, and more.

G7

Private Equity Round in 2022
G7 is a company that specializes in fleet management systems aimed at optimizing the transportation ecosystem. With a significant installation base of 800,000 cargo vehicles across China, G7 utilizes proprietary hardware devices to gather and analyze data for logistics companies and drivers. The company's platform enables businesses to locate and monitor transportation vehicles, track driver behaviors, and estimate departure and arrival times. Additionally, G7 provides detailed insights on route optimization, fuel consumption, and cargo conditions, such as temperature and humidity, which helps corporate clients and business owners enhance the efficiency of their transportation networks.

Ractigen Therapeutics

Series A in 2022
Ractigen Therapeutics is an early-stage pharmaceutical company dedicated to developing first-in-class therapies that selectively restore the expression of therapeutic genes silenced in diseased cells. Founded in 2016 by pioneers in the RNA activation field, the company leverages a groundbreaking discovery from the University of California San Francisco, known as RNA activation (RNAa). Ractigen's innovative approach aims to address diseases stemming from inadequate gene expression, with a focus on central nervous system disorders, tumors, liver diseases, and ophthalmic conditions. The company is building a promising pipeline of candidate medicines to meet significant unmet medical needs.

Air Touch

Series C in 2022
Air Touch is a Fvss dedicated to RF and microwave integrated circuit design companies, providing solutions for chips, modules, algorithms, software and even intelligent terminals. Become the world's leading supplier of microwave and millimeter wave radar chips and solutions. The technology is derived from the miniature millimeter wave short-range radar detector in the military industry. It has applied for more than 10 invention patents and has strong financial strength to support the company's sustainable development. The company dares to adopt first-class technical solutions to locate and develop world-class technology. Chip products.

Borui Jixin

Series D in 2022
Borui Jixin is a military-civilian integrated electronic information product supplier. The company focuses on the R&D and production of complete equipment and core chips in the fields of communications, radar, avionics and other fields. The products include monolithic drive amplifiers and parallel CNC attenuators. , Thin film power divider, etc.

MoonBiotech

Series C in 2021
MoonBiotech is a biotechnology company focused on the commercialization of microbial resources.

Gongda Satellite

Series A in 2021
Gongda Satellite is a commercial aerospace company that designs, manufactures on-orbit delivery commercial satellite products.

Jinyi New Material

Venture Round in 2021
Ginet New Material is a technology company providing R&D and production of inorganic non-metallic powder new material application solutions.

Time Speed

Series B in 2021
Time Speed ​​is a radio frequency integrated circuit developer, which can provide monolithic microwave integrated circuits, radio frequency integrated circuits, gallium arsenide gallium nitride power amplifier chips, low noise amplifier chips, and radio frequency front-end module chips for users in the 4G/5G communications market. And other products.

Sinomicro Medical

Series C in 2021
Sinomicro Medical is a medical device firm focused on the development of tumor ablation treatment with minimally invasive surgical robots.

Weishi Energy

Series A in 2021
Weishi Energy is a hydrogen fuel cell product research and development manufacturer, focusing on the market operation of hydrogen fuel cell technology, and is committed to promoting the low-carbon sustainable development of human energy. It is mainly engaged in the research and development, production and sales of hydrogen fuel cell products. At present, Weishi Energy has deployed five R&D centers in Shanghai, Baoding, Japan, Germany, and Canada. It has established a culturally diverse and technologically advanced R&D team, and strictly follows the V model development process to create vehicle-level fuel cell power systems and components. The company's main products include fuel cell engines, electric stacks, 35MPa/70MPa on-board hydrogen systems, bottle valves and pressure reducing valves, etc.

Vision Semiconductor Technology

Series A in 2021
The founding team of Vipas Semiconductor is composed of high-tech technical experts and market management experts from home and abroad. Relying on Nanjing University's independent innovation of vertical charge transfer imaging device (VPS) technology, it focuses on a new generation of new sensor imaging chip technology products. A high-tech company that develops and manufactures.

Immunochina

Series D in 2021
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Guangdong Xinjuneng

Venture Round in 2021
Xinjuneng Semiconductor is a semiconductor device manufacturer integrating design, research and development, and production. It is mainly oriented to the new energy vehicle and power semiconductor application market, providing users with power semiconductor packaging, modules and other products.

Yingmai Medical

Series B in 2021
Yingmai Medical offers solutions for valve intervention, aortic and peripheral intervention, and neuromodulation. They are covering multiple innovative technology fields, such as structural heart disease treatment, pan-vascular disease treatment, nerve stimulation, and a brain-computer interface platform.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.